In another ferroptosis study in hepatocellular carcinoma, WTAP was investigated as a key factor upregulating ATG5 in an m6A-YTHDC2-dependent manner and targeted inhibition of WTAP may be an innovative and effective treatment strategy for HCC (Li et al., 2024). The gene discussed is YTHDC2; the disease is hepatocellular carcinoma.